Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)

This study has been completed.
Sponsor:
Collaborators:
Genzyme, a Sanofi Company
University of Cologne
Information provided by (Responsible Party):
German CLL Study Group
ClinicalTrials.gov Identifier:
NCT01186640
First received: August 20, 2010
Last updated: September 23, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)